India Radiotherapy Devices Market By Type (External Beam Radiation Therapy Device, Internal Beam Radiation Therapy Device, Others), By Application (Breast Cancer, Cervical Cancer, Colon and rectum Cancers, Stomach Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Liver Cancer, Other), By End User (Hospitals & Clinics, Cancer Care Centers, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Radiotherapy Devices Market was valued at USD 144.20 Million in 2024 and is expected to reach USD 241.45 Million by 2030 with a CAGR of 8.93% during the forecast period. The India radiotherapy devices market is experiencing significant growth, driven by the increasing prevalence of cancer and advancements in treatment technologies. The demand for precise and effective cancer treatments has led to the rapid adoption of External Beam Radiation Therapy (EBRT) devices, particularly those utilizing advanced techniques like intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and proton therapy. Government initiatives and investments in healthcare infrastructure are expanding access to radiotherapy services, particularly in metropolitan and emerging urban centers. The market is also supported by the rise in medical tourism, as India becomes a hub for cost-effective cancer treatments.

However, challenges such as the high costs of radiotherapy devices, the need for skilled professionals to operate complex equipment, and the uneven distribution of advanced healthcare facilities across the country continue to hinder the market's potential. Despite these obstacles, increasing awareness of cancer and its early detection, coupled with efforts to enhance the healthcare system's reach, are creating a positive outlook for the market. The demand for advanced radiotherapy solutions is expected to continue rising, particularly as healthcare providers focus on expanding access in underserved regions.

Key Market Drivers

Rising Cancer Prevalence

The rising prevalence of cancer in India is a key driver of the radiotherapy devices market. As the number of cancer cases increases, the demand for advanced treatment options, such as radiotherapy, continues to rise. Early diagnosis, improved awareness, and the availability of advanced treatment techniques are critical in managing this growing health crisis. With a significant portion of the population at risk, the market for radiotherapy devices is expected to expand, supported by these rising cancer rates and the need for more sophisticated medical interventions.

The estimated number of incident cases of cancer in India for the year 2022 was found to be 14,61,427, with a crude rate of 100.4 per 100,000. The increasing number of cancer cases, particularly among the adult population, necessitates better access to treatment options, such as radiotherapy, to ensure effective tumor management and improve survival rates. As one in nine people in India is likely to develop cancer in their lifetime, the burden on the healthcare system will only intensify, driving the demand for modern radiotherapy devices to manage and treat the growing number of cancer patients.

Cervical and breast cancer are prominent among women in India, highlighting the urgent need for improved cancer care. One woman dies of cervical cancer every 8 minutes in India, underscoring the severity of this issue and the critical need for early detection and treatment. This grim statistic emphasizes the importance of advanced radiotherapy devices to effectively treat cervical cancer, which has high mortality rates, particularly in the absence of timely treatment options.

Furthermore, for every 2 women newly diagnosed with breast cancer, 1 woman dies of it in India. This alarming statistic reinforces the importance of early detection, preventive measures, and advanced therapeutic techniques, including radiotherapy. The increasing breast cancer diagnosis rates require immediate attention from healthcare systems, driving the need for more radiotherapy solutions to provide targeted, effective treatment.

In addition to the rising incidence of cancer, the high mortality from tobacco-related diseases adds to the growing burden of cancer cases. As many as 2,500 people die every day due to tobacco-related diseases in India, increasing the overall cancer burden. Tobacco use is a significant risk factor for cancers such as lung and oral cancer, driving demand for effective treatment options, including radiotherapy. The need for comprehensive cancer care and prevention strategies is growing, further propelling the demand for advanced radiotherapy devices to treat tobacco-related cancers.

Increasing Healthcare Expenditure

Increasing healthcare expenditure is a significant driver of the radiotherapy devices market in India. As households allocate more resources to healthcare, there is a growing demand for advanced medical treatments, including radiotherapy for cancer care. Rising awareness about the importance of quality healthcare, coupled with improvements in income levels, has encouraged individuals and families to seek better diagnostic and therapeutic solutions. This trend is further supported by government initiatives and private investments aimed at enhancing the country’s healthcare infrastructure, particularly in oncology.

In November 2022 alone, Indian households spent over INR 120 billion on healthcare-related expenses, according to estimates based on the Centre for Monitoring Indian Economy’s Consumer Pyramids Household Survey (CMIE-CPHS). This substantial expenditure reflects a heightened prioritization of healthcare needs across the population. Notably, 42.3% of this expenditure came from urban India, while the remaining 57.7% was attributed to rural areas, showcasing the increasing accessibility and utilization of healthcare services even in less urbanized regions. This shift in spending patterns underscores the growing acceptance and demand for advanced cancer treatments like radiotherapy, driven by a collective effort to improve health outcomes nationwide.

The increasing healthcare expenditure in India also reflects the growing penetration of advanced medical technologies, which were previously inaccessible to a significant portion of the population. As both urban and rural households invest in better healthcare services, the adoption of sophisticated treatments, such as radiotherapy, has seen a marked rise. The availability of financial assistance schemes, insurance coverage, and government-sponsored health initiatives like Ayushman Bharat has further eased the financial burden, enabling more patients to access costly yet effective cancer treatments. This is particularly critical in combating the rising prevalence of cancer across the country.

Moreover, the shift in expenditure patterns highlights the increasing focus on preventive and curative healthcare. Urban areas, with their better-developed infrastructure, continue to drive the demand for state-of-the-art radiotherapy devices, while rural regions are gradually catching up with the establishment of new cancer care facilities and diagnostic centers. The rural contribution of 57.7% to healthcare-related expenditure indicates a growing awareness and willingness among rural households to prioritize health, including advanced treatments for life-threatening diseases like cancer.

This rise in healthcare spending is expected to further fuel the development and distribution of radiotherapy devices, as healthcare providers aim to cater to a broader demographic. Increasing investments in healthcare infrastructure and the adoption of modern medical technologies are set to bridge the gap between urban and rural healthcare accessibility, ensuring the growth of the radiotherapy devices market in India.

Download Free Sample Report

Key Market Challenges

High Cost of Radiotherapy Devices

One of the major challenges in the India radiotherapy devices market is the high cost associated with purchasing, installing, and maintaining advanced radiotherapy equipment. Modern technologies like linear accelerators, proton therapy machines, and other external beam radiation devices require significant capital investment, making them unaffordable for smaller hospitals and clinics, especially in rural and semi-urban areas. Additionally, operational costs, such as regular maintenance, software upgrades, and power consumption, further strain healthcare providers' budgets.

This financial burden is compounded by the limited insurance coverage for cancer treatments in India, which often leaves patients bearing a significant portion of the treatment cost out-of-pocket. The challenge of affordability restricts the adoption of radiotherapy devices to only well-funded, high-tier hospitals, creating disparities in access to advanced cancer treatments across different regions of the country. Addressing this challenge will require collaborative efforts between the government, healthcare providers, and device manufacturers to subsidize costs, improve financing options, and develop cost-effective radiotherapy solutions.

The affordability challenge also highlights the unequal distribution of healthcare infrastructure across India, with urban centers dominating the availability of advanced radiotherapy devices, while rural and semi-urban areas remain underserved. Despite a growing cancer burden in these regions, many healthcare facilities lack the financial capacity to invest in cutting-edge radiotherapy equipment, leaving a significant portion of the population reliant on basic or outdated treatment methods. This disparity further exacerbates health inequities, as patients from underserved areas must travel long distances to access quality cancer care, adding to their financial and emotional strain.

Key Market Trends

Technological Advancements

Technological advancements are shaping the future of the radiotherapy devices market in India, bringing precision, efficiency, and improved outcomes to cancer treatment. Innovations such as image-guided radiotherapy (IGRT), intensity-modulated radiotherapy (IMRT), and stereotactic body radiotherapy (SBRT) have transformed traditional cancer care by enabling more targeted and personalized treatments. These advancements reduce damage to surrounding healthy tissues while delivering higher doses of radiation to tumors, enhancing treatment efficacy and minimizing side effects.

The introduction of artificial intelligence (AI) and machine learning in radiotherapy planning is another significant trend. AI-driven systems are streamlining treatment planning and improving accuracy by analyzing complex data sets, optimizing radiation delivery, and predicting patient responses. Furthermore, proton therapy, a cutting-edge technology, is gradually gaining traction in India, offering superior precision for treating complex and pediatric cancers.

Telemedicine and remote monitoring technologies are also making radiotherapy services more accessible, especially in underserved areas. These advancements allow specialists to collaborate remotely, ensuring that patients in remote regions can benefit from the expertise of top-tier oncologists. As India’s healthcare ecosystem continues to evolve, the adoption of these advanced technologies is not only enhancing the quality of care but also fostering greater operational efficiency within cancer treatment centers.

The increasing focus on technological innovation by both domestic and international players in the radiotherapy devices market reflects a strong commitment to addressing the country’s growing cancer burden with state-of-the-art solutions. This trend is expected to drive further growth, making advanced cancer care more effective and accessible across India.

Segmental Insights

Type Insights

Based on Type, External Beam Radiation Therapy Device have emerged as the fastest growing segment in the India Radiotherapy Devices Market in 2024. This is due to their versatility, effectiveness, and advancements in technology. EBRT devices, such as linear accelerators, offer non-invasive treatment options that are capable of targeting tumors with high precision while sparing surrounding healthy tissues. These devices are particularly effective for treating a wide range of cancers, including lung, breast, prostate, and head and neck cancers, which are among the most prevalent in India.

One of the key reasons for the rapid growth of this segment is the increasing adoption of advanced EBRT techniques such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic body radiotherapy (SBRT). These technologies provide better treatment outcomes by allowing more precise radiation delivery, reducing side effects, and improving patient quality of life. Additionally, the growing prevalence of cancer and the rising demand for effective and affordable treatment options are driving the adoption of EBRT devices across the country.

Application Insights

Based on Application, Lung Cancer have emerged as the fastest growing segment in the India Radiotherapy Devices Market during the forecast period. This growth is primarily driven by the high prevalence of lung cancer in the country, which is significantly linked to factors such as tobacco consumption, air pollution, and occupational hazards. With lung cancer being one of the leading causes of cancer-related deaths in India, there is a growing demand for advanced radiotherapy solutions to effectively treat this condition.

Radiotherapy is a crucial treatment modality for lung cancer, particularly in cases where surgery is not feasible or when used in combination with chemotherapy. Technological advancements such as stereotactic body radiotherapy (SBRT) and intensity-modulated radiotherapy (IMRT) have revolutionized lung cancer treatment by delivering high doses of radiation with precision, minimizing damage to surrounding healthy tissues, and improving patient outcomes.

The increasing awareness of early detection and the rising availability of modern radiotherapy techniques in cancer care centers are also contributing to the segment's growth. Furthermore, government and private healthcare investments aimed at improving oncology infrastructure are enabling greater access to lung cancer treatments, thereby driving the demand for radiotherapy devices for this application.

Download Free Sample Report

Regional Insights

Based on Region, North India emerged as the dominating region in the India Radiotherapy Devices Market in 2024. This is due to its well-established healthcare infrastructure, higher concentration of advanced cancer treatment centers, and greater accessibility to modern radiotherapy devices. The region is home to several leading hospitals, research institutions, and oncology centers that are equipped with state-of-the-art radiotherapy technologies, including linear accelerators and proton therapy systems. This concentration of facilities ensures that patients in North India have better access to advanced cancer care compared to other regions.

Additionally, the relatively higher awareness levels about cancer diagnosis and treatment among the population in North India have driven the demand for radiotherapy devices. Urban areas within the region, such as Delhi-NCR, Chandigarh, and Lucknow, act as hubs for medical tourism, attracting patients from across the country and neighboring regions seeking advanced oncological care. The presence of renowned healthcare providers offering specialized cancer treatments further consolidates North India’s leadership in the market.

Recent Development

• In November 2024, Sri Ramakrishna Institute of Oncology and Research (SRIOR) in Tamil Nadu has become the first comprehensive cancer center in Southern Tamil Nadu to introduce the Tomotherapy Radixact X9, a state-of-the-art radiation therapy system developed in the USA. This advanced technology offers precise, image-guided radiation treatment, enhancing tumor targeting and minimizing damage to surrounding tissues, revolutionizing cancer care in the region.
• In October 2024, Aster has launched India’s first groundbreaking Intra-Operative Electron Radiation Therapy (IOeRT) for cancer care, a revolutionary treatment that delivers targeted electron radiation during surgery. This technique allows for precise radiation directly to the tumor site while sparing surrounding healthy tissues, offering patients faster recovery times and improved outcomes, especially for cancers with complex or localized tumors.
• In September 2024, Fortis Gurugram has revolutionized cancer care by launching North India’s first MR Linac technology, combining magnetic resonance imaging (MRI) with linear accelerators for real-time imaging and precise radiation therapy. This cutting-edge technology allows for enhanced tumor targeting while minimizing damage to surrounding healthy tissues, offering a more effective and personalized treatment option for cancer patients in the region.
• In August 2023, Medanta Lucknow has launched North India's first Varian Edge radiosurgery machine, a cutting-edge technology designed for precise, non-invasive treatment of tumors. The Varian Edge offers high-definition radiation delivery, enabling doctors to target tumors with extreme accuracy while minimizing damage to surrounding healthy tissues. This advancement positions Medanta as a leader in advanced cancer care in North India.

Key Market Players

• Siemens Healthcare Diagnostics Ltd.
• Elekta Medical Systems India Pvt. Ltd
• Koninklijke Philips N.V.
• Accuray Medical Equipment India Pvt. Ltd.
• Hitachi High-Tech India Pvt. Ltd.
• Varian Medical Systems
• Healthcare Global Enterprises Ltd.

Report Scope

In this report, the India Radiotherapy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Radiotherapy Devices Market, By Type:

o   External Beam Radiation Therapy Device

o   Internal Beam Radiation Therapy Device

o   Others

• India Radiotherapy Devices Market, By Application:

o   Breast Cancer

o   Cervical Cancer

o   Colon and Rectum Cancers

o   Stomach Cancer

o   Lung Cancer

o   Prostate Cancer

o   Skin Cancer

o   Liver Cancer

o   Other

• India Radiotherapy Devices Market, By End User:

o   Hospitals & Clinics

o   Cancer Care Centers

o   Others

• India Radiotherapy Devices Market, By Region:

o   East India

o   West India

o   North India

o   South India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Radiotherapy Devices Market.

Available Customizations:

India Radiotherapy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Radiotherapy Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com